NewsRx

Search our medical news database

Drug Discovery

Holding corporation reports 25% increase in 2003 revenues

Published in Drug Week, April 23rd, 2004

Sentigen Holding Corp. (SGHL) reported results for the year and fourth quarter ended December 31, 2003.

Revenues for the year ended December 31, 2003, were $9,014,781, a 25% increase over the year ended December 31, 2002. This increase was primarily driven by growth in demand for high-throughput screening support services, mouse genetics services, and protein expression services.

Revenues for the quarter ended December 31, 2003, were $2,248,246, a 24% increase over the same period in 2002. The company's revenues are entirely attributed to the company's wholly owned operating subsidiary, Cell & Molecular Technologies, Inc.

The net...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook